Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -22.54%1.41B | -30.27%1.56B | -20.26%1.83B | -29.86%1.48B | -7.34%1.82B | 33.42%2.23B | 48.35%2.3B | 48.84%2.11B | 63.51%1.97B | 27.45%1.67B |
| Transactional financial assets | --212.36M | 11,900.00%240M | ---- | ---- | ---- | -92.86%2M | -65.92%48.11M | -65.48%52.24M | -79.21%48.24M | -78.29%28M |
| Notes receivable and accounts receivable | 2.34%1.23B | 1.53%1.19B | 2.61%1.2B | 9.47%1.24B | 6.28%1.2B | 7.67%1.17B | 9.71%1.17B | -8.23%1.14B | -7.56%1.13B | -10.16%1.08B |
| -Notes receivable | 15.59%45.56M | 16.96%56.49M | -22.74%45.38M | -10.64%38.59M | -34.56%39.42M | -31.19%48.3M | -1.85%58.74M | -36.29%43.19M | -11.30%60.23M | -25.55%70.19M |
| -Accounts receivable | 1.89%1.18B | 0.86%1.13B | 3.96%1.15B | 10.26%1.2B | 8.58%1.16B | 10.35%1.12B | 10.40%1.11B | -6.61%1.09B | -7.33%1.07B | -8.86%1.01B |
| Other receivables (including interest and dividends) | 2.55%55.78M | 6.98%58.29M | 3.52%59.18M | 6.81%54.68M | -7.93%54.39M | -5.52%54.49M | 7.90%57.17M | -57.63%51.19M | -14.77%59.08M | -16.09%57.67M |
| -Other receivable | ---- | 6.98%58.29M | ---- | ---- | ---- | -5.52%54.49M | ---- | -57.63%51.19M | ---- | -16.09%57.67M |
| Advance payment | 3.54%14.72M | -22.68%10.82M | 35.73%12.69M | -22.43%9.67M | 39.88%14.22M | 3.86%13.99M | -38.04%9.35M | 25.18%12.46M | -34.36%10.16M | -1.98%13.47M |
| Inventories | -8.42%363.45M | -23.86%335.21M | -8.47%357.69M | 1.24%369.42M | 8.55%396.87M | 21.78%440.27M | 5.94%390.77M | -12.25%364.91M | -35.80%365.6M | -44.58%361.52M |
| Receivable financing | 285.36%86.31M | 86.09%63.48M | -31.83%48.13M | -53.58%34.48M | -62.88%22.4M | -37.17%34.12M | 32.01%70.61M | 2.24%74.27M | 117.27%60.34M | 43.73%54.3M |
| Assets held for sale | ---- | --25.86M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | 44.23%106.88M | 31.92%84.86M | 76.98%89.82M | 72.79%73.8M | 65.40%74.1M | -3.60%64.33M | -18.07%50.75M | -16.42%42.71M | -8.73%44.8M | 30.29%66.73M |
| Total current assets | -2.94%3.48B | -11.18%3.56B | -12.08%3.6B | -15.04%3.26B | -2.71%3.59B | 20.05%4.01B | 23.76%4.09B | 10.53%3.84B | 8.78%3.69B | -3.85%3.34B |
| Non Current assets | ||||||||||
| Other equity investment | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M |
| Investment real estate | -1.70%1.75B | -1.70%1.75B | -1.76%1.77B | -1.76%1.77B | -4.86%1.78B | -4.22%1.78B | -2.78%1.81B | 14.66%1.81B | 15.82%1.87B | 15.05%1.86B |
| Long-term equity investment | 0.38%38.7M | 0.28%38.82M | 1.44%38.95M | 1.45%38.92M | 2.12%38.56M | -0.54%38.71M | 2.62%38.4M | 2.64%38.37M | 1.63%37.76M | 3.70%38.92M |
| Fixed assets | ---- | -3.30%1.53B | ---- | ---- | ---- | -7.95%1.58B | ---- | -11.09%1.65B | ---- | 2.40%1.72B |
| Constru in process | ---- | -5.95%26.1M | ---- | ---- | ---- | 143.39%27.75M | ---- | -85.10%11.55M | ---- | -91.50%11.4M |
| Productive biological assets | 23.65%1.07M | 24.49%1.02M | 24.84%975.92K | 27.24%926.96K | 30.32%868.96K | 33.09%822.28K | 37.15%781.73K | 40.44%728.5K | 43.72%666.79K | 48.04%617.86K |
| Intangible assets | 5.11%275.51M | 8.26%284.97M | 8.02%288.48M | -3.36%260.13M | -3.21%262.1M | -4.14%263.22M | -2.96%267.06M | -8.64%269.17M | -24.69%270.8M | -31.96%274.59M |
| Long deferred expense | 13.74%16.65M | 3.16%14.9M | -6.56%15.35M | -11.80%14.76M | -22.99%14.63M | -25.58%14.45M | -18.41%16.42M | -19.45%16.73M | -33.27%19M | -27.95%19.41M |
| Deferred tax assets | 6.83%52.08M | 0.43%50.86M | 46.09%50.32M | 44.51%51.09M | 166.71%48.75M | 167.15%50.64M | 79.33%34.44M | 29.54%35.35M | -10.24%18.28M | -7.69%18.96M |
| Usufruct assets | 1.49%109.87M | 1.56%118.83M | 93.21%118.7M | 86.35%119.81M | 77.72%108.25M | 96.01%117.01M | 3.43%61.44M | 79.84%64.29M | 56.38%60.91M | 42.95%59.7M |
| Other non current assets | 21.99%13.69M | -70.37%52.52M | -39.65%7.74M | 117.18%13.81M | 11.11%11.22M | 1,775.13%177.25M | 28.27%12.83M | -33.53%6.36M | -27.10%10.1M | -47.05%9.45M |
| Total non current assets | -1.26%3.83B | -4.55%3.86B | -0.01%3.88B | -0.55%3.88B | -2.22%3.88B | 1.05%4.05B | -3.43%3.88B | -0.91%3.9B | 0.63%3.97B | 0.84%4.01B |
| Total assets | -2.06%7.32B | -7.85%7.42B | -6.21%7.48B | -7.74%7.14B | -2.45%7.47B | 9.69%8.06B | 8.84%7.97B | 4.46%7.74B | 4.39%7.66B | -1.35%7.35B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 21.54%1.07B | 35.38%1.15B | 24.23%1.11B | 25.03%827.29M | 28.86%882.47M | 77.44%852.52M | 125.46%896.26M | 34.29%661.69M | -11.75%684.83M | -42.26%480.47M |
| Notes payable and accounts payable | -13.06%931.46M | -13.73%923.49M | -3.54%988.22M | 0.32%1.09B | 4.86%1.07B | 11.04%1.07B | 6.81%1.02B | -10.65%1.09B | -8.08%1.02B | -13.21%964.1M |
| -Notes payable | -6.76%496.55M | -20.67%453.06M | -2.99%509.78M | -0.38%578.71M | 4.91%532.53M | 20.75%571.12M | 4.58%525.51M | -7.35%580.92M | -2.92%507.62M | -19.43%472.97M |
| -Accounts payable | -19.29%434.91M | -5.80%470.43M | -4.12%478.44M | 1.14%510.88M | 4.81%538.86M | 1.68%499.37M | 9.25%498.99M | -14.17%505.15M | -12.67%514.14M | -6.24%491.13M |
| Contract liabilities | -27.22%8.46M | 53.47%12.27M | -22.42%11.46M | 62.43%11.53M | -22.92%11.62M | -16.03%7.99M | 78.01%14.78M | 30.49%7.1M | -40.66%15.07M | -59.99%9.52M |
| Advance receipts | 514.02%4.38M | 740.66%13.31M | 56.17%2.83M | -25.88%1.03M | -33.18%712.89K | -17.72%1.58M | 340.44%1.81M | -57.82%1.39M | 3,531.67%1.07M | 210.83%1.92M |
| Salaries payable | -3.26%44.23M | -6.77%50.52M | -6.32%44.07M | 6.42%55.68M | 15.47%45.72M | 16.48%54.19M | 11.95%47.05M | -16.77%52.32M | -3.36%39.59M | 19.61%46.52M |
| Taxs payable | 7.20%56.71M | 29.86%46.28M | 29.35%51.36M | 0.38%41.08M | 22.51%52.9M | 5.31%35.64M | -6.00%39.71M | -30.24%40.93M | -15.77%43.18M | -19.87%33.84M |
| Other payable (including interest and dividends) | 1.66%50.01M | -57.17%107.61M | -25.04%44.17M | -6.47%54.04M | -22.12%49.19M | 264.07%251.27M | -3.84%58.92M | -15.52%57.78M | 8.50%63.17M | 23.41%69.02M |
| -Dividend payable | ---- | -68.32%63.06M | ---- | ---- | ---- | --199.07M | ---- | ---- | ---- | ---- |
| -Other payable | ---- | -14.65%44.55M | ---- | ---- | ---- | -24.37%52.19M | ---- | -15.52%57.78M | ---- | 23.41%69.02M |
| Non current liabilities due within one year | -25.45%236.53M | -24.37%241.2M | -89.49%38.44M | -53.11%129.53M | 1,164.11%317.27M | 1,070.53%318.92M | 1,246.71%365.82M | 1,216.70%276.21M | 22.50%25.1M | -78.60%27.25M |
| Other current liabilities | -58.18%1.12M | -56.77%1.56M | -16.55%1.85M | 161.22%3.84M | 57.18%2.68M | 336.13%3.6M | 119.42%2.21M | -54.50%1.47M | -28.71%1.7M | -67.07%826.5K |
| Total current liabilities | -1.17%2.41B | -1.77%2.55B | -6.33%2.3B | 1.31%2.21B | 28.41%2.43B | 58.94%2.6B | 59.24%2.45B | 13.14%2.18B | -9.15%1.9B | -26.89%1.63B |
| Current liabilities | ||||||||||
| Long term loan | -24.93%26.28M | -17.50%28.88M | 503.22%211.16M | -76.04%31.51M | -90.81%35.01M | -90.82%35.01M | -91.92%35.01M | -52.43%131.51M | 492.92%380.96M | 694.80%381.51M |
| Deferred tax liabilities | -0.14%183.04M | -1.66%181.98M | 4.51%182.14M | 4.59%182.72M | 12.76%183.29M | 13.90%185.05M | 5.27%174.28M | 13.13%174.7M | 10.57%162.54M | 10.30%162.46M |
| Long term deferred income | -51.01%27.39M | -6.27%53.19M | -2.75%53.99M | -6.22%54.82M | -1.20%55.9M | -1.17%56.74M | -4.67%55.52M | 3.38%58.46M | -9.70%56.58M | -9.53%57.41M |
| Lease liabilities | -1.80%86.08M | 0.09%93.22M | 101.88%95.78M | 119.68%95.98M | 130.13%87.66M | 173.85%93.14M | 36.48%47.44M | 134.01%43.69M | 76.26%38.09M | 46.66%34.01M |
| Other non current liabilities | -36.78%3.44M | -36.78%3.44M | 0.00%5.44M | 22.53%5.44M | --5.44M | --5.44M | --5.44M | --4.44M | ---- | ---- |
| Total non current liabilities | -11.18%326.23M | -3.91%360.7M | 72.66%548.51M | -10.25%370.46M | -42.45%367.3M | -40.92%375.37M | -54.08%317.69M | -18.44%412.79M | 115.95%638.17M | 125.36%635.39M |
| Total liabilities | -2.48%2.73B | -2.04%2.91B | 2.73%2.84B | -0.53%2.58B | 10.56%2.8B | 30.97%2.97B | 24.10%2.77B | 6.58%2.6B | 6.37%2.53B | -9.83%2.27B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.53B | 0.00%1.53B | 0.00%1.53B | 0.00%1.53B | 0.00%1.53B | 0.00%1.53B | 0.00%1.53B | 0.00%1.53B | 0.00%1.53B | 0.00%1.53B |
| Capital reserve funds | -0.06%1.24B | 0.00%1.24B | 0.00%1.24B | 0.00%1.24B | 0.00%1.24B | 0.00%1.24B | 0.00%1.24B | 0.00%1.24B | 0.00%1.24B | 0.00%1.24B |
| Surplus reserve funds | 2.59%354.01M | 2.59%354.01M | 35.02%345.94M | 35.02%345.94M | 38.56%345.08M | 38.56%345.08M | 2.88%256.21M | 2.88%256.21M | 0.33%249.04M | 0.33%249.04M |
| Retained profit | -8.28%778.15M | -45.34%694.12M | -45.36%807.05M | -48.38%726.69M | -38.56%848.44M | -3.85%1.27B | 8.75%1.48B | 6.64%1.41B | 6.49%1.38B | 2.70%1.32B |
| Other composite income | -2.92%617.27M | -1.09%625.19M | 1.11%642.25M | 0.39%645.93M | -3.67%635.87M | -6.18%632.09M | -3.15%635.21M | 12.34%643.39M | 15.05%660.12M | 19.38%673.74M |
| Shareholders equity without minority interests | -1.75%4.52B | -11.43%4.45B | -11.15%4.57B | -11.58%4.49B | -9.09%4.6B | 0.07%5.02B | 2.09%5.14B | 3.37%5.08B | 3.50%5.06B | 2.97%5.02B |
| Minority interests | -6.17%60.32M | 3.24%65.38M | 4.38%64.15M | 5.31%63.76M | 8.49%64.28M | 8.92%63.33M | 8.33%61.46M | 7.80%60.55M | -1.53%59.25M | 3.52%58.14M |
| Total shareholder equity | -1.81%4.58B | -11.24%4.51B | -10.96%4.63B | -11.39%4.56B | -8.89%4.67B | 0.17%5.08B | 2.16%5.2B | 3.42%5.14B | 3.44%5.12B | 2.98%5.08B |
| Total liabilityies and equity | -2.06%7.32B | -7.85%7.42B | -6.21%7.48B | -7.74%7.14B | -2.45%7.47B | 9.69%8.06B | 8.84%7.97B | 4.46%7.74B | 4.39%7.66B | -1.35%7.35B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.